Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR Will the Restless Leg Syndrome Market Achieve During 2025–2034, and What Does It Indicate?

Over the past few years, the market size for restless leg syndrome has significantly increased. It is projected to expand from $1.91 billion in 2024 to $2.17 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.8%. The expansion witnessed in the historical timeframe can be linked to a surge in alcohol consumption, enhanced health insurance coverage, the availability of over-the-counter drugs, the rise in public health campaigns, and an uptick in mental health problems.

Expectations are high for the restless leg syndrome market as it is set to expand rapidly in the coming years. It is forecasted to reach a worth of $3.59 billion in 2029, growing at a compound annual growth rate (CAGR) of 13.4%. This surge in growth over the forecast period can be attributed to factors such as escalated investments in healthcare, greater awareness through education campaigns, an increase in early detection rates, enhanced government funding, and more participation in clinical trials. Being in the forecast period, substantial trends include AI-driven personalized treatment approaches, next-gen neurostimulation devices, deep learning diagnosis algorithms, brainwave modulation technologies, and wearable exoskeletons for leg movements.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the Restless Leg Syndrome Market?

The rise in iron deficiency cases is poised to fuel the expansion of the restless leg syndrome market in the future. Iron deficiency, a state where the body cannot produce enough healthy red blood cells due to insufficient iron, brings about symptoms such as weakness, tiredness, and pale complexion. The escalating incidences of iron deficiency can be attributed to a combination of poor diet, loss of blood, malabsorption disorders, and heightened iron demands during pregnancy or growth. The treatment of restless leg syndrome regularly entails iron supplementation or dietary changes, which not only help soothe the disturbing urges and sensations but also aim to rectify the underlying iron deficiency by restoring the body’s iron reserves, enhancing red blood cell creation, and reestablishing normal neurological function. For instance, the National Health Service England, a government agency based in England, reported in January 2025 that during the 2023-24 period, there were 191,927 admissions due to iron deficiency, marking an 11% rise from 2022-23. As a result, the increasing incidence of iron deficiency is propelling the growth of the restless leg syndrome market.

Get Your Free Sample of the Global Restless Leg Syndrome Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=21274&type=smp

Who Are the Key Firms Paving the Way for Growth in the Restless Leg Syndrome Market?

Major companies operating in the restless leg syndrome market are Pfizer Inc., Roche Holding AG, Merck & Co Inc., Novartis International AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Baxter International Inc., Astellas Pharma Inc., UCB S.A., Kyowa Kirin Co Ltd., Amneal Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Mundipharma International Limited, Azurity Pharmaceuticals LLC, Otsuka Pharmaceutical Co Ltd., Horizon Therapeutics plc, Mylan N.V., Apollo Pharmacy Limited

What Are the Most Influential Trends Currently Shaping the Restless Leg Syndrome Market?

Leading firms in the restless leg syndrome (RLS) market are prioritizing the creation of innovative strategies, such as new non-invasive approaches, to better manage symptoms and enhance patient outcomes. New non-invasive treatments are ground-breaking medical solutions that do not necessitate surgical intervention or skin penetration, aiming to alleviate different conditions using sophisticated techniques like electrical stimulation, light therapy, or external gadgets. For example, Varco Leg Care, a consumer health-technology firm from India, was granted FDA De Novo approval for its NTX100 Tonic Motor Activation (TOMAC) System in April 2023. This system, specifically designed to address moderate to severe RLS symptoms and bolster sleep quality in patients unresponsive to medicines, operates by electrically stimulating the peroneal nerves on both body sides to induce steady muscle activation that is sleep-friendly. This action aids in lessening the symptoms of restless leg syndrome (RLS).

Get Instant Access to the Global Restless Leg Syndrome Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/restless-leg-syndrome-global-market-report

What Are the Major Segments of the Restless Leg Syndrome Market and Their Role in Driving Growth?

The restless leg syndrome market covered in this report is segmented –

1) By Type: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome

2) By Treatment Type: Medicine And Devices, Surgery

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By Application: Neurological Treatment, Sleep Disorders, Movement Disorders, Symptom Management

Subsegments:

1) By Primary Restless Legs Syndrome: Idiopathic Restless Legs Syndrome, Hereditary Restless Legs Syndrome

2) By Secondary Restless Legs Syndrome: Iron Deficiency-related Restless Legs Syndrome, Chronic Kidney Disease-related Restless Legs Syndrome, Pregnancy-related Restless Legs Syndrome, Medication-induced Restless Legs Syndrome

Which Regions Are Essential for the Growth of the Restless Leg Syndrome Market?

Europe was the largest region in the restless leg syndrome market in 2024. North-America is expected to be the fastest-growing region in the forecast period. The regions covered in the restless leg syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Restless Leg Syndrome Market Defined?

Restless leg syndrome refers to a neurological condition characterized by an uncontrollable urge to move the legs, typically due to uncomfortable sensations. Treatment options include lifestyle changes, iron supplements, medications that affect dopamine levels, and strategies to improve sleep hygiene.

Browse Through More Similar Reports By The Business Research Company:

Anemia and Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Stem Cell/Cord Blood Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Blood Bank Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-bank-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: